Literature DB >> 22416265

Effects of social cognitive impairment on speech disorder in schizophrenia.

Nancy M Docherty1, Amanda McCleery, Marielle Divilbiss, Emily B Schumann, Aubrey Moe, Mohammed K Shakeel.   

Abstract

Disordered speech in schizophrenia impairs social functioning because it impedes communication with others. Treatment approaches targeting this symptom have been limited by an incomplete understanding of its causes. This study examined the process underpinnings of speech disorder, assessed in terms of communication failure. Contributions of impairments in 2 social cognitive abilities, emotion perception and theory of mind (ToM), to speech disorder were assessed in 63 patients with schizophrenia or schizoaffective disorder and 21 nonpsychiatric participants, after controlling for the effects of verbal intelligence and impairments in basic language-related neurocognitive abilities. After removal of the effects of the neurocognitive variables, impairments in emotion perception and ToM each explained additional variance in speech disorder in the patients but not the controls. The neurocognitive and social cognitive variables, taken together, explained 51% of the variance in speech disorder in the patients. Schizophrenic disordered speech may be less a concomitant of "positive" psychotic process than of illness-related limitations in neurocognitive and social cognitive functioning.

Entities:  

Mesh:

Year:  2012        PMID: 22416265      PMCID: PMC3627757          DOI: 10.1093/schbul/sbs039

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  31 in total

1.  Positive and negative affect recognition in schizophrenia: a comparison with substance abuse and normal control subjects.

Authors:  M Bell; G Bryson; P Lysaker
Journal:  Psychiatry Res       Date:  1997-11-14       Impact factor: 3.222

2.  Audiotape playback as a technique in the treatment of schizophrenic patients.

Authors:  S L Satel; W H Sledge
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

3.  The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

Authors:  B A Cornblatt; N J Risch; G Faris; D Friedman; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1988-11       Impact factor: 3.222

4.  Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability.

Authors:  N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1979-11

5.  Attention and clinical symptoms in schizophrenia.

Authors:  B Cornblatt; M Obuchowski; D B Schnur; J D O'Brien
Journal:  Psychiatr Q       Date:  1997

6.  Attribution of intentions to others in people with schizophrenia: a non-verbal exploration with comic strips.

Authors:  Y Sarfati; M C Hardy-Baylé; C Besche; D Widlöcher
Journal:  Schizophr Res       Date:  1997-06-20       Impact factor: 4.939

7.  Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia.

Authors:  R Corcoran; G Mercer; C D Frith
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

8.  Communication disturbances in schizophrenia and mania.

Authors:  N M Docherty; M DeRosa; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1996-04

9.  A comparative study of manic vs schizophrenic speech disorganization.

Authors:  R E Hoffman; S Stopek; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1986-09

10.  Exploring 'theory of mind' in people with schizophrenia.

Authors:  C D Frith; R Corcoran
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more
  9 in total

1.  The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life in schizophrenia.

Authors:  Emre Mutlu; Hatice Abaoğlu; Elif Barışkın; Ş Can Gürel; Aygün Ertuğrul; M Kazım Yazıcı; Esra Akı; A Elif Anıl Yağcıoğlu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-01-17       Impact factor: 4.328

2.  Facial emotion perception in schizophrenia: Does sex matter?

Authors:  Jasmine Mote; Ann M Kring
Journal:  World J Psychiatry       Date:  2016-06-22

Review 3.  Can RDoC Help Find Order in Thought Disorder?

Authors:  Alex S Cohen; Thanh P Le; Taylor L Fedechko; Brita Elvevåg
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

4.  Formal thought disorder in autism spectrum disorder predicts future symptom severity, but not psychosis prodrome.

Authors:  Mart L J M Eussen; Esther I de Bruin; Arthur R Van Gool; Anneke Louwerse; Jan van der Ende; Fop Verheij; Frank C Verhulst; Kirstin Greaves-Lord
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 4.785

5.  Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders.

Authors:  Reno Kriz; Sunghye Cho; Sunny X Tang; Suh Jung Park; Jenna Harowitz; Raquel E Gur; Mahendra T Bhati; Daniel H Wolf; João Sedoc; Mark Y Liberman
Journal:  NPJ Schizophr       Date:  2021-05-14

6.  Automatic Schizophrenia Detection Using Multimodality Media via a Text Reading Task.

Authors:  Jing Zhang; Hui Yang; Wen Li; Yuanyuan Li; Jing Qin; Ling He
Journal:  Front Neurosci       Date:  2022-07-14       Impact factor: 5.152

7.  Referential communication in people with recent-onset schizophrenia-spectrum disorders.

Authors:  Amélie M Achim; André Achim; Marion Fossard
Journal:  Front Psychiatry       Date:  2022-09-09       Impact factor: 5.435

8.  Is There Any Relation Between Impaired Emotion Perception and Thought Disorder in Schizophrenia?

Authors:  Elif Yildirim; Berna Yalinçetin; Şilay Sevilmiş; Özge Kutay; Köksal Alptekin
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

9.  The link between formal thought disorder and social functioning in schizophrenia: A meta-analysis.

Authors:  Matthew P Marggraf; Paul H Lysaker; Michelle P Salyers; Kyle S Minor
Journal:  Eur Psychiatry       Date:  2020-03-23       Impact factor: 5.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.